Patent details

Basic Information

Publication number:

EP2819670

PCT Application Number:

US2013028097

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP137086252

PCT Publication Number:

WO2013130669

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PHARMACEUTICAL COMPOSITION AND ADMINISTRATION THEREOF

French Title of Invention:

COMPOSITION PHARMCEUTIQUE ET LEURS ADMINISTRATIONS

German Title of Invention:

PHARMAZEUTISCHE ZUBEREITUNG UND DEREN VERABREICHUNGEN

SPC Number:

Dates

Filing date:

27/02/2013

Grant date:

20/05/2026

EP Publication Date:

07/01/2015

PCT Publication Date:

06/09/2013

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

20/05/2026

EP B1 Publication Date:

20/05/2026

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

27/02/2033

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

13/05/2026

 

 

Name:

Vertex Pharmaceuticals Incorporated

Address:

50 Northern Avenue, Boston, MA 02210, United States (US)

Inventor

1

Name:

KUZMISSION, Andrew, G.

Address:

United States (US)

2

Name:

HURTER, Patricia, Nell

Address:

United States (US)

3

Name:

DOKOU, Eleni

Address:

United States (US)

4

Name:

DAS, Laura

Address:

United States (US)

5

Name:

JOHNSTON, Meghan, M.

Address:

United States (US)

6

Name:

CAESAR, John, P., Jr.

Address:

United States (US)

7

Name:

GU, Chong-Hui

Address:

United States (US)

8

Name:

ISRANI, Meghna, Jai

Address:

United States (US)

9

Name:

JAMZAD, Shahla

Address:

United States (US)

10

Name:

FAWAZ, Majed

Address:

United States (US)

11

Name:

KNEZIC, Dragutin

Address:

United States (US)

12

Name:

WANG, Hongren

Address:

United States (US)

Priority

1

Priority Number:

201261603882 P

Priority Date:

27/02/2012

Priority Country:

United States (US)

2

Priority Number:

201261710352 P

Priority Date:

05/10/2012

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/47; A61K 9/16; A61K 47/02; A61K 47/26; A61K 47/32; A61K 47/38;

Publication

European Patent Bulletin

Issue number:

202621

Publication date:

20/05/2026

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

01/03/2027

Annual Fee Number:

15

Annual Fee Amount:

213 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages